different approaches have been used to search for the sensitive criteria in assessing the bioavailability of Mn source. Most experiments conducted to evaluate the bioavailability of Mn from different Mn sources were based on the Mn accumulation in the tissues of animals (Henry, Ammerman, & Miles, 1989; Scheideler, 1991) . In addition, heart manganese-containing superoxide dismutase (MnSOD) activity was a specific index for assessing Mn status and requirements for chicks (Luo, Su, Huang, & Liu, 1991) . Further studies showed that MnSOD mRNA level in heart was more sensitive than MnSOD activity or commonly used bone Mn in the assessing Mn bioavailability from different Mn source (Li et al., 2004; Luo et al., 2007; Wang et al., 2012 . Several studies found that humate was used a part of replacement therapy for digestive system disturbances such as malnutrition and diarrhoea in calve and chicks (Griban, Baranahenko, Kasyan, & Verlos, 1991; Shermer, Maciorowski, Bailey, Byers, & Ricke, 1998) . Humate supplementation also increased the feed conversion efficiency in poultry (Kocabağli, Alp, Acar, & Kahraman, 2002; Yörük, Gül, Hayirli, & Macit, 2004) . However, no literature was found on the bioavailability of metal from humate-metal complex in animals.
Therefore, the objective of this study was to investigate the relative bioavailability of humate-Mn complex compared with the Mn sulphate for broilers fed a conventional corn-soya bean meal diet.
| MATERIAL S AND ME THODS
All animals used in this study were cared for strictly following the current regulations on the care, use and handling of experimental animals that was approved by the Animal Health and Care Committee of Sichuan Agricultural University, in accordance with Chinese legislation on animal welfare.
| Structural characteristics and chelation property of humate-Mn complex
The humate-Mn complex (Beijing Silong Biotechnology, Beijing, China) was synthesized with Mn sulphate adding directly to a neutral solution of potassium humate of known humate concentration.
And then, the precipitated humate-Mn was dissolved upon further addition of alkali to give soluble, approximately neutral, humate-Mn.
The organic element of humate-Mn complex was determined by the high-performance liquid chromatography combined with tandem mass spectrometry (Varian 1200L Quadrupole LC/MS/MS System, Walnut Creek, CA), and the results showed that the humate-Mn contained 48.0% C, 33.5% O, 3.9% H and 0.5% N. The O:C ratio for humate-Mn was 0.52, and the H:C ratio for humate-Mn was 0.99.
These values showed that the organic basic unit of humate-Mn complex consisted of an aromatic nucleus with aliphatic side chains up to 10 carbon atoms. The structural characteristics of humate-Mn complex were determined by the Fourier transform infrared spectrometer (Perkin Elmer Spectrum One FT-IR Spectrometer, Perkin Elmer, Switzerland). The infrared spectrum of humic acid gave several characteristic peaks (Supporting Information Figure S1 ). The peaks at the wavelength of 1658 and 1,454/cm represent the carboxyl (COO − ) or (C=O) group of humic acid, and the peak at a wavelength of 1,227/cm corresponds to the carbon hydroxyl bond (C-OH) of humic acid. The spectra of the humate-Mn product displayed some differences (Supporting Information Figure S1 ). The characteristic peaks of carboxyl group (1658 and 1,454/cm) and carbon hydroxyl bond (1,227 cm/) from humic acid had disappeared in humate-Mn complex, and the peaks were detected at the wavelength of 1,157
and 929/cm, corresponding to carboxyl oxygen bond (C-O). The latter bond is consistent with complex or chelate bonds between Mn and humic acid in the humate-Mn complex.
The chelation effectiveness of humate-Mn complex was determined as described by Holwerda, Albin, and Madsen (1995) Q f -value, was 1,145, and the humate-Mn showed very strong chelation (Q f -value > 1,000) based on the classification described by Holwerda et al. (1995) .
| Animals and diets
A total of 560 1-day-old Arbor Acres commercial male chicks were randomly allotted by body weight to one of eight replicate cages (10 chicks per cage) for each of seven treatment groups in a completely randomized design involving a 2 × 3 factorial arrangement of treatments (two sources of Mn and three concentrations of added Mn) plus a control with no added Mn. All birds were housed in electrically heated, thermostatically controlled cages (100 × 80 × 50 cm)
with fibreglass feeders and a 24-hr constant light schedule. The birds were allowed ad libitum access to the experimental diets and tap water that contained no detectable Mn (<0.02 mg/L). Birds were weighted, and feed intake was recorded at 14 days of age.
The basal corn-soya bean meal diet (Table 1) Dietary Mn concentrations are presented in Table 2 .
| Sample collections and preparations
On day 14, one bird from each cage was selected according to the average BW within the cage after a 12-hr fast, individually weighted and collected 5-ml blood sample from the right wing vein. After collection, the bird was scarified by cervical dislocation. The heart tissue was excised, and a subsample was frozen at −20°C for Mn concentration and MnSOD activity analysis, and another subsample was frozen in liquid nitrogen for MnSOD gene expression assays.
The liver and the right tibia were excised and frozen in an individual heat-sealed polyethylene bag for Mn analysis.
| Mn concentration
The concentrations of Mn in Mn sources, diets, water, plasma, livers, hearts and tibias were determined by an atomic absorption spectrophotometer (Model ContrAA 700; Analytik Jena AG, Jena, Germany)
as described by Bai et al. (2014) . Blood was centrifuged at 3,500 g for 15 min to collect plasma sample. The tibia was determined on a wet-tissue basis after removing the adhering tissues and then ashed in a muffle furnace at 600°C for 24 hr. The heart and liver were also determined on a wet-tissue basis. Approximately 0.5 g of feed, liver, heart or tibia ash, or 0.5 ml of plasma or water was digested with 9 ml of HNO 3 and 1 ml of HF using microwave digestion system (Mars 6; CEM Corporation, Matthews, NC). A bovine liver standard (NBS Standard Reference Material, USDC, Washington, DC) was included in all analyses to verify the determination accuracy.
| Heart MnSOD activity
The heart subsamples were homogenized by sonication in sucrose buffer solution (10 mM Tris-HCl at pH 7.4, 0.25 mM sucrose and 1 mM EDTA). The MnSOD activity was measured in the supernatant obtained after centrifugation at 15,000 g for 20 min at 4°C using a SOD Assay Kit (A001-2; Nanjing Jiancheng Bioengineering Institute, Nanjing, China). The MnSOD activity was assessed by an ultraviolet spectrometer (SmartSpec 3000; Bio-Rad, Hercules, CA). The protein concentration was determined by the Bradford method using bovine serum albumin as the standard.
| RNA isolation and real-time PCR
Total RNA in heart tissue was extracted using TRIzol (Invitrogen, was 95°C for 15 min, followed by forty cycles of 95°C for 5 s and 60°C
for 30 s, and a final melting curve analysis. The primers for MnSOD (forward, 5′-TTCCTGACCTGCCTTACGACTAT-3′, reverse, 5′-CCAGCGCCTCTTTGTATTTCT-3′; PCR product length 138 bp) and reference gene β-actin (forward, 5′-GCTACAGCTTCACCACCACA-3′, reverse, 5′-TCTCCTGCTCGAAATCCAGT-3′; PCR product length 90 bp) were used for the amplification reactions respectively. Genespecific amplification was determined by melting curve analysis and agarose gel electrophoresis. Relative quantities of mRNA were calculated using the 2 −ΔΔCt method with the quantity of the control group scaled to 1 (Livak & Schmittgen, 2001 ). The β-actin was selected as the reference gene (Bai et al., 2014) .
| Statistical analyses
To test the effect of supplemental Mn, data were analysed using single degree of freedom contrast to compare all supplemental
Mn treatments with the control (Li et al., 2004 errors (SEs) were estimated using the method of error propagation as described by Littell, Henry, Lewis, and Ammerman (1997) .
Difference between the two Mn sources was determined by difference in their respective regression coefficients. The p < 0.05 was considered to be statistically significant.
| RE SULTS

| Growth performance of broilers
The supplemental Mn treatments decreased (p < 0.05) feed intake (FI) and the ratio of feed intake:body weight gain (F:G), whereas it did not influence (p > 0.20) BW at 14 days of age and body weight gain (BWG) from day 1 to day 14 as compared to the control group ( 
| Mn deposition in different tissues
Compared with the chicks fed the control diet, the chicks fed diets supplemented with Mn had higher (p < 0.04) Mn concentrations in the plasma, liver, tibia and heart (Table 4) Mn concentration than those fed the diet supplemented with either 60 or 120 mg Mn/kg regardless of Mn source.
| Activity and mRNA abundance of heart MnSOD
The activity and mRNA abundance of heart MnSOD were higher (p < 0.05) in the supplemental Mn treatments as compared to the control treatment, and they increased linearly (p < 0.001) with added Mn level increasing (Table 5) . The Mn source, added Mn level and their interaction had no influence (p > 0.12) on heart MnSOD activity. However, the chicks fed with the diet added with 180 mg Mn/ kg had higher (p < 0.001) mRNA abundance of heart MnSOD than those fed with the diet added with 60 and 120 mg Mn/kg regardless of Mn source.
| Relative bioavailability estimate of humate-Mn
The were estimated based on slope ratios from multiple linear regressions of Mn concentrations in the plasma and heart, and the activity and mRNA abundance of heart MnSOD on the amount of Mn intake ( 
| D ISCUSS I ON
The bioavailability of trace minerals is defined as the proportion of the ingested element that is absorbed, transported to its site of action and converted to a physiologically active form. Thus, bioavailability implied not only absorption, but also utilization of the mineral for a specific function. However, it was difficult to quantitatively evaluate the actual utilization of an element with a response criterion of sufficient sensitivity to determine statistical differences with a small population of animals. Growth performance is one method to measure Mn utilization but is generally a fairly unresponsive criterion for many mineral elements (Halpin & Baker, 1987; Smith & Kabaija, 1985) . In this study, the increases in feed intake and the ratio of feed intake:body weight gain in the chicks fed with the control diet with no added Mn showed that the Mn level in the control diet (27.23 mg Mn/kg) was not sufficient for the growth of broilers, which was in consistent with previous findings (Li et al., 2004 (Li et al., , 2005 . Tissue accumulation was considered to be a sensitive criterion for Mn utilization (Henry et al., 1989; Li et al., 2004; Scheideler, 1991) . In this study, no significant difference in Mn concentrations in the liver, heart and tibia of broilers fed different Mn source suggested there was the similar bioavailability between Mn sulphate and humate-Mn for the starter broilers (1-14 days) . However, the lower plasma Mn 
TA B L E 6
Relative bioavailability values (RBVs) of Mn based on multiple linear regressions of Mn concentrations in plasma and heart, and the activity and mRNA abundance of heart MnSOD on the amount of daily Mn intake for broilers concentration in humate-Mn fed chicks indicated the chicks fed the supplemental humate-Mn diet absorbed the less Mn than those fed with supplemental sulphate Mn diet, majorly due to reduced feed intake resulting from humate-Mn supplementation. These results supported the previous view that the plasma Mn was a biomarker to evaluate the Mn uptake from the intestine of broilers (Bai et al., 2012; Bai, Lu, Luo, & Liu, 2008) .
The Mn is a crucial component of the metalloenzyme MnSOD.
Several previous studies showed that the activity and mRNA abundance of heart MnSOD linearly increased as dietary Mn levels increased when chicks fed diets supplemented with 60-180 mg of Mn/kg of diet for 21 days (Li et al., 2004 (Li et al., , 2005 Wang et al., 2012) . Luo et al. (2007) found that the heart MnSOD mRNA level was a more sensitive criterion for assessing the relative bioavailabilities of Mn sources than Mn accumulation in the tissues of broilers. In the present study, no significant difference in the activity and mRNA abundance of heart MnSOD also suggested the bioavailability of
Mn from humate-Mn was the similar to that from Mn sulphate for the starter broilers (1-14 days). Results of multiple linear regressions also showed that there were the similar bioavailabilities of Mn between humate-Mn complex and Mn sulphate for the starter broilers.
Previous studies have shown that the bioavailabilities of organic Mn sources for broilers were closely related to their chelation strengths (Li et al., 2004 (Li et al., , 2005 Luo et al., 2007; . The organic Mn source with the moderate chelation strength displayed the highest relative bioavailability, followed by one with the strong chelation strength, and that with the weak chelation strength was as available as Mn sulphate. In present study, the humate-Mn complex with the very strong chelation had similar bioavailability to that of Mn sulphate. The reason of the disparity seems to be due to the difference in Q f . Holwerda et al. (1995) classified Additionally, the addition of humates can improve the cell-mediated immunity and alleviate some of the toxic effect of aflatoxin in growing broilers (Shermer et al., 1998) . In the present study, the decrease in feed intake and the tendency of BW reduction by humate-Mn supplementation indicated the humate-Mn addition decreased the appetite of broilers for the food. These results were consistent with the previous finding described by Kocabağli et al. (2002) for the starter broilers (1-21 days), but were not insistent with previous reports that the humate supplementation did not influence or increase the performance of broilers from day 1 to day 42 (Bailey, White, & Donke, 1996; Kocabağli et al., 2002 ).
Performance differences due to humate supplementation observed in the literature might result from the differences in the physiological period, the composition of diets and the commercially available humate products. The underlying of mechanism of decreased feed intake by humate-Mn needs to be further research in poultry.
In conclusion, Mn concentrations in the plasma and heart, and the activity and mRNA expression level of heart MnSOD increased as di-
etary Mn concentration increased in the starter broilers (1-14 days).
Based on slope ratios from multiple linear regressions of the above four indices on added Mn level, the bioavailability of humate-Mn was similar to that of Mn sulphate for the starter broilers (1-14 days).
ACK N OWLED G EM ENTS
The study was supported by Sichuan International Cooperation 
